Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricDVADaVitaLHLabcorpDGXQuest Diagnostics
Snapshot
Price$179.25$334.32$241.65
Market cap$15.08B$23.53B$23.88B
Valuation
P/E14.7x29.2x26x
Forward P/E13.8x22.4x22.7x
Growth
Revenue growth6.7%7.3%11.0%
EPS growth6.6%30.2%14.9%
Profitability
Net margin5.7%6.7%9.1%
ROE181.2%10.9%14.1%
Balance sheet & cash
Debt / equity77.99x0.66x0.82x
Free cash flow yield8.2%5.2%5.4%
Dividend yield—1.1%1.7%
Verdict
Investment ratingNeutral· 53Neutral· 52Neutral· 52

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearDVAtoday $179LHtoday $334DGXtoday $242
2027$143.32 – $210.21+17% CAGR$326.36 – $478.67+43% CAGR$208.21 – $305.37+26% CAGR
2028$152.80 – $224.10+12% CAGR$424.79 – $623.03+37% CAGR$239.19 – $350.81+20% CAGR
2029$162.90 – $238.92+10% CAGR$552.91 – $810.94+34% CAGR$274.78 – $403.01+19% CAGR
2030$173.66 – $254.71+9% CAGR$719.67 – $1,055.52+33% CAGR$315.66 – $462.97+18% CAGR
2031$185.14 – $271.54+9% CAGR$936.72 – $1,373.86+33% CAGR$362.64 – $531.87+17% CAGR
5-yr CAGR0.6% – 8.7%22.9% – 32.7%8.5% – 17.1%